High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$663K
$663,556
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
ORKA
M
Oruka Therapeutics, Inc.
Goncalves Joana
• Officer • Chief Medical Officer
Other
2026-02-17
$51,240x2
|
||||||
| ORKA |
Oruka Therapeutics, Inc.
|
Officer • Chief Medical Officer
Other
|
2026-02-17 | $51,240x2 | M | Form 4 |
|
ORKA
S
Oruka Therapeutics, Inc.
Goncalves Joana
• Officer • Chief Medical Officer
10b5-1 Sell
2026-02-17
$226,559x2
|
||||||
| ORKA |
Oruka Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-02-17 | $226,559x2 | S | Form 4 |
|
ORKA
M
Oruka Therapeutics, Inc.
Goncalves Joana
• Officer • Chief Medical Officer
Other
2026-01-15
$51,240x2
|
||||||
| ORKA |
Oruka Therapeutics, Inc.
|
Officer • Chief Medical Officer
Other
|
2026-01-15 | $51,240x2 | M | Form 4 |
|
ORKA
S
Oruka Therapeutics, Inc.
Goncalves Joana
• Officer • Chief Medical Officer
10b5-1 SellΔOwn -51.4%
2026-01-15
$222,704x2
|
||||||
| ORKA |
Oruka Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 SellΔOwn -51.4%
|
2026-01-15 | $222,704x2 | S | Form 4 |
|
ORKA
M
Oruka Therapeutics, Inc.
Goncalves Joana
• Officer • Chief Medical Officer
Equity Compensation
2025-12-19
$51,240x3
|
||||||
| ORKA |
Oruka Therapeutics, Inc.
|
Officer • Chief Medical Officer
Equity Compensation
|
2025-12-19 | $51,240x3 | M | Form 4 |
|
ORKA
S
Oruka Therapeutics, Inc.
Goncalves Joana
• Officer • Chief Medical Officer
10b5-1 Sell
2025-12-19
$214,293x4
|
||||||
| ORKA |
Oruka Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-12-19 | $214,293x4 | S | Form 4 |